Ame Company For Medical Supplies (9527.SR) — Cash flow
Operating, investing, and financing cash flow for Ame Company For Medical Supplies — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 35↓22.9% | 45↑35.5% | 34↑25.6% | 27↑25.7% | 21 | |
| Depreciation & Amortization | 2↓12.7% | 2↑18.9% | 2↑79.9% | 0.85↑86.0% | 0.46 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -81↓80.9% | -45↓1010.0% | -4↑77.1% | -18↓123.9% | -8 | |
| Accounts Receivable | -34↓23.7% | -27↓105.5% | -13↓4417.7% | -0.30↑97.7% | -13 | |
| Inventory | -36↓35.5% | -26↓2171.0% | 1↑105.9% | -22↓622.8% | -3 | |
| Accounts Payable | 6↑40.7% | 4↑688.0% | 0.51↑307.4% | -0.25↓200.8% | 0.24 | |
| Other Working Capital | -17↓425.5% | 5↓31.5% | 8↑68.9% | 4↓43.7% | 8 | |
| Other Non-Cash Items | 18↑404.8% | -6↓206.9% | 6↑495.6% | -1↓122.0% | 6 | |
| Net Cash from Operating Activities | -26↓632.0% | -4↓109.7% | 37↑332.5% | 8↓58.2% | 20 | |
| Operating Cash Flow | -26↓632.0% | -4↓109.7% | 37↑332.5% | 8↓58.2% | 20 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -1↓130.7% | -0.50↑73.9% | -2↓137.4% | -0.81↓143.1% | -0.34 | |
| Capital Expenditure | -0.75↓116.0% | -0.35↑82.0% | -2↓137.4% | -0.81↓143.1% | -0.34 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.08 | |
| Purchases of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash from Investing Activities | -1↓130.7% | -0.50↑73.9% | -2↓137.4% | -0.81↓213.8% | -0.26 | |
| Financing Activities | ||||||
| Net Debt Issuance | 27↑2883.2% | -0.97↓120.6% | -0.44↓9.8% | -0.40↑91.1% | -5 | |
| Long-Term Net Debt Issuance | 0.00↑100.0% | -0.97↓120.6% | -0.44↓9.8% | -0.40↑91.1% | -5 | |
| Short-Term Net Debt Issuance | 27 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -14↓0.1% | -14↑0.0% | -14↓14.2% | -12↓665.6% | -2 | |
| Common Dividends Paid | -14↓0.1% | -14↑0.0% | -14↓14.2% | -12↓665.6% | -2 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -0.32↓89.8% | -0.17↑17.2% | -0.21↓98.9% | -0.10↑44.6% | -0.19 | |
| Net Cash from Financing Activities | 13↑184.1% | -15↓3.4% | -15↓14.8% | -13↓102.9% | -6 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -14↑24.6% | -19↓195.6% | 20↑494.1% | -5↓137.1% | 14 | |
| Cash at Beginning of Period | 24↓44.2% | 43↑86.1% | 23↓17.9% | 28↑93.3% | 15 | |
| Cash at End of Period | 10↓59.8% | 24↓44.2% | 43↑86.1% | 23↓17.9% | 28 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -27↓585.9% | -4↓111.2% | 35↑353.3% | 8↓61.6% | 20 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.